Have a personal or library account? Click to login

Showing 1-7 of 7 for the term ""Zwitter, Matjaz""

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
Article

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor

Smrdel, Uros, Popovic, Mara, Zwitter, Matjaz, Bostjancic, Emanuela, Zupan, Andrej, Kovac, Viljem, Glavac, Damjan, Bokal, Drago, Jerebic, Janja
Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors
Article

Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors

Zwitter, Matjaz, Rossi, Antonio, Di Maio, Massimo, Perme, Maja Pohar, Lopes, Gilberto
Glioblastoma patients in Slovenia from 1997 to 2008
Article

Glioblastoma patients in Slovenia from 1997 to 2008

Smrdel, Uros, Kovac, Viljem, Popovic, Mara, Zwitter, Matjaz
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
Article

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival

Stanic, Karmen, Zwitter, Matjaz, Turnsek Hitij, Nina, Kern, Izidor, Sadikov, Aleksander, Cufer, Tanja
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
Article

Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients

Kovac, Viljem, Zwitter, Matjaz, Zagar, Tina
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations
Article

Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations

Zwitter, Matjaz, Stanic, Karmen, Rajer, Mirjana, Kern, Izidor, Vrankar, Martina, Edelbaher, Natalija, Kovac, Viljem
Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial
Article

Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial

Vrankar, Martina, Zwitter, Matjaz, Bavcar, Tanja, Milic, Ana, Kovac, Viljem